Viewing Study NCT01545427


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-16 @ 2:43 AM
Study NCT ID: NCT01545427
Status: TERMINATED
Last Update Posted: 2012-03-07
First Post: 2012-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module